Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties
- PMID: 2836623
- PMCID: PMC253401
- DOI: 10.1128/JVI.62.7.2427-2436.1988
Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties
Abstract
Moloney murine leukemia virus (M-MuLV) is a replication-competent retrovirus which induces T-cell lymphoma in mice. The enhancer sequences present within the M-MuLV long terminal repeat (LTR) region of the proviral genome have been shown to influence the disease specificity of the virus strongly. We examined the contribution of the M-MuLV enhancers to the transcriptional activity and pathogenesis of M-MuLV by constructing LTRs containing heterologous enhancer elements. The simian virus 40 enhancer region (72- and 21-base-pair repeats) was inserted into the U3 region (at -150 base pairs) of the M-MuLV LTR (Mo + SV) and also into a deleted form of the LTR which lacks the M-MuLV enhancer sequences (delta Mo + SV). These chimeric LTRs were used to generate infectious M-MuLVs by transfection of corresponding proviral plasmids into mouse fibroblasts. The relative infectivities of Mo + SV and delta Mo + SV recombinant viruses as determined by rat XC cell plaque assay and reverse transcriptase assay were 60 to 70% of wild-type M-MuLV levels. To study the pathogenicity of these two recombinant viruses, we inoculated newborn NIH Swiss mice with either Mo + SV or delta Mo + SV M-MuLV. Both viruses induced disease more slowly than M-MuLV, which induces disease 2 to 4 months postinoculation. Mo + SV M-MuLV-inoculated animals became moribund at 3 to 13 months postinoculation, whereas delta Mo + SV M-MuLV-inoculated animals became moribund at 6 to 24 months postinoculation. The tumors induced by the two viruses were characterized histologically and molecularly. Mo + SV M-MuLV-induced tumors were primarily T-cell-derived lymphoblastic lymphomas containing extensive rearrangements of the T-cell receptor beta gene. In contrast, delta Mo + SV M-MuLV induced pre-B- and B-cell lymphoblastic lymphomas, B-cell-derived follicular-center cell lymphomas, and acute myeloid leukemia. The delta Mo + SV tumor DNAs from B-lineage tumors were typically rearranged at the immunoglobulin gene loci and contained germ line configurations of the T-cell receptor beta gene. Southern blot hybridization confirmed that the tumor DNAs contained the predicted Mo + SV M-MuLV or delta Mo + SV M-MuLV provirus.
Similar articles
-
Rearrangements and insertions in the Moloney murine leukemia virus long terminal repeat alter biological properties in vivo and in vitro.J Virol. 1986 Oct;60(1):204-14. doi: 10.1128/JVI.60.1.204-214.1986. J Virol. 1986. PMID: 3747027 Free PMC article.
-
Leukemogenicity of Moloney murine leukemia viruses carrying polyoma enhancer sequences in the long terminal repeat is dependent on the nature of the inserted polyoma sequences.Virology. 1988 Sep;166(1):58-65. doi: 10.1016/0042-6822(88)90146-8. Virology. 1988. PMID: 2842957
-
Escape from in vivo restriction of Moloney mink cell focus-inducing viruses driven by the Mo+PyF101 long terminal repeat (LTR) by LTR alterations.J Virol. 1993 Dec;67(12):7140-8. doi: 10.1128/JVI.67.12.7140-7148.1993. J Virol. 1993. PMID: 8230436 Free PMC article.
-
M-MuLV reverse transcriptase: Selected properties and improved mutants.Comput Struct Biotechnol J. 2021 Nov 22;19:6315-6327. doi: 10.1016/j.csbj.2021.11.030. eCollection 2021. Comput Struct Biotechnol J. 2021. PMID: 34900141 Free PMC article. Review.
-
Enhancing B-Cell Malignancies-On Repurposing Enhancer Activity towards Cancer.Cancers (Basel). 2021 Jun 29;13(13):3270. doi: 10.3390/cancers13133270. Cancers (Basel). 2021. PMID: 34210001 Free PMC article. Review.
Cited by
-
Enhanced replication and pathogenesis of Moloney murine leukemia virus in mice defective in the murine APOBEC3 gene.Virology. 2009 Mar 15;385(2):455-63. doi: 10.1016/j.virol.2008.11.051. Epub 2009 Jan 15. Virology. 2009. PMID: 19150103 Free PMC article.
-
Substitution of murine transthyretin (prealbumin) regulatory sequences into the Moloney murine leukemia virus long terminal repeat yields infectious virus with altered biological properties.J Virol. 1990 Dec;64(12):6130-40. doi: 10.1128/JVI.64.12.6130-6140.1990. J Virol. 1990. PMID: 2173784 Free PMC article.
-
An enhancer variant of Moloney murine leukemia virus defective in leukemogenesis does not generate detectable mink cell focus-inducing virus in vivo.Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2264-8. doi: 10.1073/pnas.88.6.2264. Proc Natl Acad Sci U S A. 1991. PMID: 2006167 Free PMC article.
-
Recombinant mink cell focus-inducing virus and long terminal repeat alterations accompany the increased leukemogenicity of the Mo+PyF101 variant of Moloney murine leukemia virus after intraperitoneal inoculation.J Virol. 1995 Feb;69(2):1037-43. doi: 10.1128/JVI.69.2.1037-1043.1995. J Virol. 1995. PMID: 7815481 Free PMC article.
-
Novel insights into the pathogenesis of the Graffi murine leukemia retrovirus.J Virol. 2006 Apr;80(8):4026-37. doi: 10.1128/JVI.80.8.4026-4037.2006. J Virol. 2006. PMID: 16571819 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources